Latest News & Features
Big Pharma
Pfizer has announced that it will provide all of its current and future patent-protected medicines and vaccines—that are available in the US or EU—on a not-for-profit basis to 45 lower-income countries. 31 May 2022
Generics
Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue. 27 May 2022
Genetics
UK legislation to streamline gene-editing technology research is promising for innovation, but presents potential complications for IP, finds Sarah Speight. 26 May 2022
Big Pharma
The UK Supreme Court has ruled that regulators such as the Competition and Markets Authority should be required to pay the costs of a party successfully appealing against one of their infringement decisions. 26 May 2022
Europe
The case reinforced the need for interim injunction applications to be made as quickly as possible, explains Lydia Birch of EIP. 26 May 2022
Asia-Pacific
The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International. 24 May 2022
Genetics
OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice. 24 May 2022
Generics
South Africa’s Supreme Court has declared regulations on complementary medicines invalid, explain Kareema Shaik and Jenny Pienaar of Adams & Adams. 23 May 2022
article
The Medicines Patent Pool and World Health Organization’s COVID-19 Technology Access Pool have signed a deal aiming to open up new technologies to people living in poorer countries. 19 May 2022
Americas
The US Patent and Trademark Office has argued against a bid by medical device maker Arthrex, which wants recognition that an ex-interim acting director lacked the power to refuse to review its petition. 19 May 2022